Cipher Pharmaceuticals Inc.

TSX:CPH Stock Report

Market Cap: CA$212.4m

Cipher Pharmaceuticals Management

Management criteria checks 2/4

Cipher Pharmaceuticals' CEO is Craig Mull, appointed in Jul 2019, has a tenure of 4.75 years. directly owns 2.98% of the company’s shares, worth CA$6.34M. The average tenure of the management team and the board of directors is 3.5 years and 3 years respectively.

Key information

Craig Mull

Chief executive officer

US$567.6k

Total compensation

CEO salary percentagen/a
CEO tenure4.8yrs
CEO ownership3.0%
Management average tenure3.5yrs
Board average tenure3yrs

Recent management updates

Recent updates

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

CEO

Craig Mull

4.8yrs

Tenure

US$567,581

Compensation

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...


Leadership Team

NamePositionTenureCompensationOwnership
Craig Mull
Interim CEO & Chairman of the Board4.8yrsUS$567.58k2.98%
$ 6.3m
Bryan Jacobs
Chief Financial Officer1.7yrsUS$438.28k0.021%
$ 44.0k
Diane Gajewczyk
Vice President of Scientific & Medical Affairs5.8yrsUS$322.57k0.35%
$ 740.4k
Emilio Presti
Director of Sales & Marketing2.3yrsno datano data

3.5yrs

Average Tenure

Experienced Management: CPH's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Craig Mull
Interim CEO & Chairman of the Board5.1yrsUS$567.58k2.98%
$ 6.3m
Harold Wolkin
Lead Independent Director7.7yrsUS$60.85k1.51%
$ 3.2m
Douglas Deeth
Independent Directorless than a yearno datano data
Hubert Walinski
Independent Directorless than a yearno datano data

3.0yrs

Average Tenure

Experienced Board: CPH's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.